Efficacy of hydroxyethyl starch and haemaccel for the treatment of severe ovarian hyperstimulation syndrome.
Gamzu
Ronni
R
Almog
Benny
B
Levin
Yishai
Y
Avni
Amiram
A
Lessing
Joseph B
JB
Baram
Amiram
A
D000328:Adult; D005260:Female; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use*; D016471:Ovarian Hyperstimulation Syndrome / Q000188:drug therapy* / Q000503:physiopathology*; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011097:Polygeline / Q000627:therapeutic use*; D012720:Severity of Illness Index
D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes; D011097:Polygeline